CABOLONG is an advanced oncology-grade formulation of Cabozantinib, designed to target and treat multiple types of cancers with high precision and efficacy. Available in 20mg and 60mg strengths, CABOLONG delivers a powerful therapeutic option for patients diagnosed with various malignancies, including renal cell carcinoma (RCC), hepatocellular carc